Evidence map›Paper›PMID 36093022›Full record

ArticleChemical science2022

An N-capping asparagine-lysine-proline (NKP) motif contributes to a hybrid flexible/stable multifunctional peptide scaffold.

Marlon H Cardoso, Lai Y Chan, Elizabete S Cândido, Danieli F Buccini, Samilla B Rezende, Marcelo D T Torres, Karen G N Oshiro, Ítala C Silva, Sónia Gonçalves, Timothy K Lu and 4 more

Abstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Computer-Aided Design ofACS medicinal chemistry letters · 2026
    Article
  3. Article
  4. Cathelicidin-like Peptide for ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Marlon H CardosoS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco Avenida Tamandaré 6000 Campo Grande - MS 79117900 Brazil marlonhenrique6@gmail.com d.craik@imb.uq.edu.au ocfranco@gmail.com.ORCID https://orcid.org/0000-0001-6676-5362
Lai Y ChanInstitute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland Brisbane QLD, 4072 Australia.ORCID https://orcid.org/0000-0002-9346-2487
Elizabete S CândidoS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco Avenida Tamandaré 6000 Campo Grande - MS 79117900 Brazil marlonhenrique6@gmail.com d.craik@imb.uq.edu.au ocfranco@gmail.com.
Danieli F BucciniS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco Avenida Tamandaré 6000 Campo Grande - MS 79117900 Brazil marlonhenrique6@gmail.com d.craik@imb.uq.edu.au ocfranco@gmail.com.
Samilla B RezendeS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco Avenida Tamandaré 6000 Campo Grande - MS 79117900 Brazil marlonhenrique6@gmail.com d.craik@imb.uq.edu.au ocfranco@gmail.com.ORCID https://orcid.org/0000-0002-4820-3638
Marcelo D T TorresMachine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, Departments of Bioengineering and Chemical and Biomolecular Engineering, School of Engineering and Applied Science, Penn Institute for Computational Science, University of Pennsylvania Philadelphia Pennsylvania USA.ORCID https://orcid.org/0000-0002-6165-9138
Karen G N OshiroS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco Avenida Tamandaré 6000 Campo Grande - MS 79117900 Brazil marlonhenrique6@gmail.com d.craik@imb.uq.edu.au ocfranco@gmail.com.ORCID https://orcid.org/0000-0002-8813-6433
Ítala C SilvaInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa Lisbon Portugal.ORCID https://orcid.org/0000-0002-4589-2757
Sónia GonçalvesInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa Lisbon Portugal.
Timothy K LuSynthetic Biology Group, MIT Synthetic Biology Center, The Center for Microbiome Informatics and Therapeutics, Research Laboratory of Electronics, Department of Biological Engineering, Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology Cambridge - MA 02139 USA.
Nuno C SantosInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa Lisbon Portugal.ORCID https://orcid.org/0000-0002-0580-0475
Cesar de la Fuente-NunezMachine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, Departments of Bioengineering and Chemical and Biomolecular Engineering, School of Engineering and Applied Science, Penn Institute for Computational Science, University of Pennsylvania Philadelphia Pennsylvania USA.ORCID https://orcid.org/0000-0002-2005-5629
David J CraikInstitute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland Brisbane QLD, 4072 Australia.ORCID https://orcid.org/0000-0003-0007-6796
Octávio L FrancoS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco Avenida Tamandaré 6000 Campo Grande - MS 79117900 Brazil marlonhenrique6@gmail.com d.craik@imb.uq.edu.au ocfranco@gmail.com.ORCID https://orcid.org/0000-0001-9546-0525

Funding

Combining chemical and computational tools for predictive models of microbiome communitiesR35GM138201 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI DE LA FUENTE, CESAR · 2020 to 2024
$1.8M
NIGMS NIH HHS R35 GM138201
6 · The paper itself

Abstract

Structural diversity drives multiple biological activities and mechanisms of action in linear peptides. Here we describe an unusual N-capping asparagine-lysine-proline (NKP) motif that confers a hybrid multifunctional scaffold to a computationally designed peptide (PaDBS1R7). PaDBS1R7 has a shorter α-helix segment than other computationally designed peptides of similar sequence but with key residue substitutions. Although this motif acts as an α-helix breaker in PaDBS1R7, the Asn5 presents exclusive N-capping effects, forming a belt to establish hydrogen bonds for an amphipathic α-helix stabilization. The combination of these different structural profiles was described as a coil/N-cap/α-helix scaffold, which was also observed in diverse computational peptide mutants. Biological studies revealed that all peptides displayed antibacterial activities. However, only PaDBS1R7 displayed anticancer properties, eradicated

Identifiers

PMID36093022
PMCPMC9383710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.